Ferit Aslan
Overview
Explore the profile of Ferit Aslan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sekmek S, Ozsan Celebi S, Bayram D, Erol C, Kos F, Sendur M, et al.
Sci Rep
. 2024 Nov;
14(1):29785.
PMID: 39616250
We aimed to compare FOLFIRI and bevacizumab with FOLFIRI and aflibercept in terms of overall survival (OS), progression-free survival (PFS) and safety in patients with RAS-mutant metastatic colon cancer who...
2.
Bardakci M, Karakas H, Bayram D, Avci N, Kitapli S, Ozen M, et al.
Sci Rep
. 2024 May;
14(1):10632.
PMID: 38724585
While some clinics have adopted abbreviated neoadjuvant treatment for HER2-positive breast cancer, there remains a shortage of comprehensive clinical data to support this practice. This is a retrospective, multicenter study....
3.
Yildirim H, Kapar C, Koksal B, Seyyar M, Sanci P, Guliyev M, et al.
J Chemother
. 2024 Mar;
37(1):69-75.
PMID: 38497444
The only phase 3 study on the effectiveness of CDK 4-6 inhibitors in first-line treatment in premenopausal patients with hormone receptor (HR) positive, HER2 negative metastatic breast cancer is the...
4.
Yildirim H, Kutlu Y, Mutlu E, Aykan M, Korkmaz M, Yalcin S, et al.
Int J Clin Oncol
. 2024 Feb;
29(3):258-265.
PMID: 38310597
Introduction: Male breast cancer, comprising approximately 1% of all breast cancer cases, often leads to the exclusion of male patients as a criterion in clinical trials. While the efficacy of...
5.
Karacin C, Oksuzoglu B, Demirci A, Keskinkilic M, Baytemur N, Yilmaz F, et al.
BMC Cancer
. 2023 Feb;
23(1):192.
PMID: 36849943
No abstract available.
6.
Karacin C, Oksuzoglu B, Demirci A, Keskinkilic M, Baytemur N, Yilmaz F, et al.
BMC Cancer
. 2023 Feb;
23(1):136.
PMID: 36765293
Background: There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent kinase 4/6 inhibitor (CDK4/6) based therapy. We aimed to evaluate which...
7.
Alyanak A, Aslan F
Cureus
. 2022 Sep;
14(8):e28089.
PMID: 36127982
Introduction Our aim in this study is to examine the clinical features of gallbladder polyps (GBPs) detected by preoperative ultrasonography (USG) or after cholecystectomy, especially benign and malignancy. Methods One...
8.
Aslan F, Gunaydin E, Yukruk F, Guvenc I, Gencler O
Cureus
. 2022 May;
14(4):e23796.
PMID: 35518520
In glioblastoma multiforme (GBM) cases, the tumor usually remains limited to the central nervous system in the expected disease course. Here, we discuss the case of a 41-year-old male patient...
9.
Budakoglu B, Sugunes T, Aslan F, Oner S, Nadir A
Cureus
. 2022 Apr;
14(3):e23236.
PMID: 35449690
Aims And Objectives: To examine the impact of the workforce crisis on healthcare service delivery for a year during the coronavirus disease 2019 (COVID-19) pandemic on healthcare service delivery and...
10.
Yildiz F, Demirci U, Kucukarda A, Buyuksimsek M, Sakalar T, Topcu T, et al.
J Cancer Res Ther
. 2021 Dec;
17(6):1525-1529.
PMID: 34916389
Background: Merkel cell carcinoma (MCC) is a rare but highly aggressive neuroendocrine carcinoma of the skin. In this study, we aimed to evaluate the clinicopathologic characteristics, treatment outcomes, and survival...